How Ancient Denisovan DNA Continues to Shape Human Immunity Thousands of Years Later

Genetic Echoes of a Vanished Human Species

Thousands of years after the Denisovans disappeared from the face of the Earth, their genetic legacy lives on — not as dormant biological baggage, but as actively functioning DNA that continues to shape how modern humans fight disease and develop physically. A sweeping new study from Yale University has uncovered some of the most compelling evidence yet that ancient interbreeding between early humans and the mysterious Denisovans left behind genetic variants that remain biologically active in people alive today.

The research, published on June 11 in the journal Science, represents one of the most thorough analyses of human genetic diversity across Oceania ever conducted — a region whose populations have long been overlooked in mainstream genomics research.

A Critical Gap in Genetics Research

Despite being home to some of the most genetically diverse populations on the planet, communities across the South Pacific have historically been underrepresented in large-scale genomic studies. The vast majority of genetics research has centered on individuals of European ancestry, leaving significant blind spots in our understanding of human evolutionary history.

"The drastic underrepresentation of Oceanians limits our understanding of human evolution and could exacerbate health inequalities as genomic research is used to develop novel medical treatments," said lead author Serena Tucci, assistant professor of anthropology at Yale's Faculty of Arts and Sciences and principal investigator of the Yale Human Evolutionary Genomics Laboratory.

To address this imbalance, Tucci's team launched an ambitious project to expand the global map of human genetic variation, with a particular focus on identifying inherited traits passed down from extinct hominin relatives.

Sequencing the Genomes of Near Oceania

For the study, researchers sequenced the complete genomes of 177 individuals drawn from 12 distinct populations across Near Oceania — a region encompassing Papua New Guinea, the Bismarck Archipelago, and the Solomon Islands. These newly generated genomes were then analyzed alongside 1,284 previously published genomes from populations around the world.

By tracing the genetic history of some of humanity's earliest Pacific settlers — populations whose ancestors arrived in the region at least 45,000 years ago — the research team uncovered striking new details about human migration, adaptation, and interbreeding with now-extinct relatives.

Among the study's most remarkable revelations: the ancestors of Near Oceanian peoples interbred with at least three separate and distinct groups of Denisovans, an extinct branch of the human family tree first identified through fossil remains found in a Siberian cave.

Denisovan DNA Is Not Just a Relic — It's Still Working

Previous research had established that DNA from extinct hominins such as Neanderthals and Denisovans survives in scattered fragments throughout modern human genomes. What sets this new study apart is the team's ability to demonstrate that this inherited DNA isn't simply sitting dormant — it is actively switching genes on and off.

"With this study we have moved beyond simply 'resurrecting' this DNA to showing how it actively turns genes on and off, which is game-changing," said Tucci. "This DNA is not just a remnant of ancient liaisons; it continues to influence our biology today."

To investigate exactly how these ancient genetic variants function, the researchers employed a cutting-edge technique known as a massively parallel reporter assay. This method allows scientists to directly test the impact of hundreds or thousands of genetic variants on gene activity simultaneously. The analysis pinpointed more than 3,100 variants capable of altering gene expression in measurable ways.

Ancient Immunity Boosters

A significant portion of the functionally active Denisovan variants identified in the study were connected to the interferon-gamma signaling pathway — a critical component of the human immune system responsible for defending the body against bacterial and viral infections.

According to Patrick Reilly, first author of the study and associate research scientist at the Yale Human Evolutionary Genomics Laboratory, this finding makes evolutionary sense. As ancient human populations migrated into new environments, they encountered unfamiliar pathogens that posed serious threats to survival.

"Pathogens are one of the strongest selective pressures throughout human evolution," Reilly explained. "We find evidence that genes inherited from Denisovans bolstered immunity to viruses and bacteria ancient humans encountered in Near Oceania."

In other words, interbreeding with Denisovans may have given early modern humans a crucial immunological advantage — one that natural selection then preserved and passed down through countless generations.

Skeletal Development and a Surprising Evolutionary Pattern

The study's findings extend beyond immunity. Researchers also identified Denisovan-derived genetic variants linked to skeletal development, specifically within a gene called TRPS1.

What makes this discovery particularly intriguing is that the same gene shows signs of strong positive selection in two entirely unrelated populations: central African rainforest hunter-gatherers and highland communities in Ecuador. This parallel pattern of adaptation — occurring independently across vastly different environments and populations — suggests that certain evolutionary solutions are so effective that nature arrives at them repeatedly.

A Legacy Written in DNA

The broader implication of this research is profound. Although the Denisovans vanished from the Earth long ago, their biological influence persists in the people who inhabit the Pacific today — and likely in populations beyond that region as well.

"While Denisovans vanished from the Earth thousands of years ago, this research proves that our histories remain deeply intertwined," Tucci noted.

The study was supported by funding from the National Institute of General Medical Sciences and the National Human Genome Research Institute, both part of the National Institutes of Health. Coauthors came from Yale University, Binghamton University, Temple University, and the Papua New Guinea Institute for Medical Research.